Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence.

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)1047-1059
    JournalPharmacoeconomics
    Volume22
    Issue number16
    Publication statusPublished - 1 Jan 2004

    Keywords

    • PHARMACOLOGY & PHARMACY

    Cite this